Skip to main content
Caplight Logo









AyuVis Research

AyuVis Research

Private
Fort Worth, TexasHealthcare & Life Scienceshttps://www.ayuvis.com/

Last Round

Grant

May 15, 2023

Total Funding Raised

$9M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

AyuVis Research is a biopharmaceutical company that develops novel small molecule immunotherapies to prevent and treat inflammatory and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

small molecule immunotherapybronchopulmonary dysplasiaBPDclinical stage biopharmaOrphan Drugneonatal drug developmentbiotech startupinnate immune modulationRare Pediatric Diseaserespiratory disease treatmentSBIR grantacute respiratory distress syndromeARDSventilator-associated pneumoniaVAP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AyuVis Research Comparables

Compare AyuVis Research with similar companies based on industry and business-model similarity.

AyuVis Research comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Airway Therapeutics
89%
orphanix GmbH
82%
EXO Biologics
78%

AyuVis Research Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 15, 2023
GrantMay 12, 2022
GrantJan 1, 2017

Key People

Founding team and executive leadership

Suchismita Acharya

Chief Executive Officer (Primary Employment)

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors increased 90% MoM.

  • Jan 19, 2026

    Monthly visitors grew 68% MoM, reaching 1.8K.

AyuVis Research Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AyuVis Research Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AyuVis Research's valuation, stock price, and market status.

Firmographic Details

HeadquartersFort Worth, Texas
Employee Range10
Year Founded2014
Last FundingMay 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?